These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22243489)

  • 1. 1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.
    Del Bello F; Barocelli E; Bertoni S; Bonifazi A; Camalli M; Campi G; Giannella M; Matucci R; Nesi M; Pigini M; Quaglia W; Piergentili A
    J Med Chem; 2012 Feb; 55(4):1783-7. PubMed ID: 22243489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
    Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.
    Piergentili A; Quaglia W; Giannella M; Del Bello F; Bruni B; Buccioni M; Carrieri A; Ciattini S
    Bioorg Med Chem; 2007 Jan; 15(2):886-96. PubMed ID: 17084634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
    Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
    J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.
    Piergentili A; Quaglia W; Del Bello F; Giannella M; Pigini M; Barocelli E; Bertoni S; Matucci R; Nesi M; Bruni B; Di Vaira M
    Bioorg Med Chem; 2009 Dec; 17(24):8174-85. PubMed ID: 19896386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
    Peretto I; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Cerri A; Menegon S; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Bassani F; Delcanale M; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1693-7. PubMed ID: 17352463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
    J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory mechanism of BRL37344 on muscarinic receptor-mediated contractions of the rat urinary bladder smooth muscle.
    Kubota Y; Nakahara T; Yunoki M; Mitani A; Maruko T; Sakamoto K; Ishii K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):198-203. PubMed ID: 12172701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.
    Glossop PA; Watson CA; Price DA; Bunnage ME; Middleton DS; Wood A; James K; Roberts D; Strang RS; Yeadon M; Perros-Huguet C; Clarke NP; Trevethick MA; Machin I; Stuart EF; Evans SM; Harrison AC; Fairman DA; Agoram B; Burrows JL; Feeder N; Fulton CK; Dillon BR; Entwistle DA; Spence FJ
    J Med Chem; 2011 Oct; 54(19):6888-904. PubMed ID: 21870878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase activity in rat urinary bladder detrusor: participation in M3 and M4 muscarinic receptor function.
    Orman B; Sterin-Borda L; Reina S; Borda ES
    Auton Autacoid Pharmacol; 2005 Jul; 25(3):93-100. PubMed ID: 15955028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
    Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
    Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
    J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
    Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.
    Finney SM; Stewart LH; Gillespie JI
    BJU Int; 2007 Sep; 100(3):668-78. PubMed ID: 17627783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.
    Piergentili A; Quaglia W; Giannella M; Del Bello F; Buccioni M; Nesi M; Matucci R
    Bioorg Med Chem Lett; 2008 Jan; 18(2):614-8. PubMed ID: 18077164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
    Sagara Y; Sagara T; Uchiyama M; Otsuki S; Kimura T; Fujikawa T; Noguchi K; Ohtake N
    J Med Chem; 2006 Sep; 49(19):5653-63. PubMed ID: 16970392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of bencycloquidium bromide, a novel muscarinic M(3) receptor antagonist in guinea pig airways.
    Jiang JX; Cao R; Deng WD; Jin F; Dong XW; Zhu Y; Chen XP; Xie YC; Bao MJ; Li FF; Xie QM
    Eur J Pharmacol; 2011 Mar; 655(1-3):74-82. PubMed ID: 21272572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle.
    Choppin A; Eglen RM; Hegde SS
    Br J Pharmacol; 1998 Jul; 124(5):883-8. PubMed ID: 9692772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.